Patient Assistance Programs
 
Fighting AIDS in Africa
 
Bristol-Myers Squibb Foundation & Corporate Philanthropy
 
Product Integrity
 
Sustainability: Our Plan for Responsible Growth
 
Environment, Health & Safety Policy
 
Medical Education Grants And Charitable Contributions
 
Clinical Outcomes And Research Grants
 
Position On Key Issues

 

  » BMS.com Home » Corporate Responsibility » Honoraria
SEARCH INDEX

Honoraria

BMS does not compensate faculty for participation in medical education activities; this is the responsibility of the program provider. Nevertheless, BMS remains concerned about payments to faculty that are, or may be perceived to be, excessive.

BMS recognizes that honoraria proposed to be paid by grantees should be consistent with fair market values and of sufficient levels to attract qualified, respected faculty to participate in such programs. While precise amounts have not been established, the following rates may be used as guides based on the caliber of the faculty, as well as, the task at hand and the time and commitment involved.

  • Single Presentation: $3,500 maximum for national level faculty
  • Chair and Speaker: $5,000 maximum
  • Full Day: $7,500 maximum

Notwithstanding these levels, no individual should receive in excess of $20,000 for speaking and other work in connection with any single CME project unless a compelling justification can be made for such honoraria to be paid.

Grants provided by BMS for IME will not be used to fund costs associated with speakers or faculty employed by or affiliated with the institution sponsoring the event, when the intended audience is employed or affiliated with the institution for purposes of internal education.

 

 

 

 




[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

 

Our Medical Grants and Charitable Contributions program supports educational initiatives.
SEARCH INDEX